Was AstraZeneca CEO Pascal Soriot happy with his $14.8M in '18 compensation? Probably not so much
AstraZeneca CEO Pascal Soriot made headlines when he moaned about the poor pay he took home for 2017, forced to live on about $13 million in total compensation. That made him one of the worst paid — though certainly not the worst — big pharma execs in the world. So he’s not likely to be much more excited by the small growth in compensation he had for last year.
In a newly filed annual report, Astrazeneca revealed that Soriot’s annual compensation swelled to £11.3 million, up from £10.4 million for the year before. That’s a bump of 9%. Translated to dollars, that’s $14.8 million for all of 2018, with a tiny raise in base salary (to £1.25 million) and a smaller bonus, with better long-term incentives.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.